Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Biomedicines|April 30, 2021
Bromodomain and Extraterminal Protein Inhibitor, Apabetalone (RVX-208), Reduces ACE2 Expression and Attenuates SARS-Cov-2 Infection In VitroDean Gilham, Audrey L Smith, Li Fu, et al.
Structure (London, England : 1993)|June 18, 2022
Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infectionKendra R Vann, Arpan Acharya, Suk Min Jang, et al.
Cancer Research Communications|July 31, 2025
Gut Microbiome Profiling in Eμ-TCL1 Mice Reveals Intestinal Changes and a Dysbiotic Signature Specific to Chronic Lymphocytic LeukemiaSydney A Skupa, Kathryn M Cooper, Audrey L Smith, et al.
International Journal of Molecular Sciences|June 24, 2022
A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic LeukemiaAudrey L Smith, Alexandria P Eiken, Sydney A Skupa, et al.
Human Molecular Genetics|November 17, 2023
Heterogeneity in the progression of retinal pathologies in mice harboring patient mimicking Impg2 mutationsBrittany N Williams, Adam Draper, Patrick F Lang, et al.
Molecular Autism|December 26, 2024
Comparative profiling of white matter development in the human and mouse brain reveals volumetric deficits and delayed myelination in Angelman syndromeSiddhi S Ozarkar, Ridthi K-R Patel, Tasmai Vulli, et al.
Nature Communications|July 8, 2024
Ube3a unsilencer for the potential treatment of Angelman syndromeHanna Vihma, Kelin Li, Anna Welton-Arndt, et al.
Cancer Research Communications|April 30, 2024
Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical EffectsAlexandria P Eiken, Audrey L Smith, Sydney A Skupa, et al.
Scientific Reports|June 25, 2024
TLR9 agonism differentially impacts human NK cell-mediated direct killing and antibody-dependent cell-mediated cytotoxicityAnna R Mahr, Maia M C Bennett-Boehm, Frederik H Rothemejer, et al.
JCI Insight|May 22, 2024
BET inhibition reforms the immune microenvironment and alleviates T cell dysfunction in chronic lymphocytic leukemiaAudrey L Smith, Sydney A Skupa, Alexandria P Eiken, et al.
Pageof 2